1. From MTD Towards Metronomic
Chemotherapy: The Role of the Tumor Microenvironment, the AIMS Conference on Dynamical Systems, Differential Equations and
Applications in Madrid, Spain, July 7-11, 2014.
2. Tumor Heterogeneity and its Effects on Optimal Drug
Administration, the AIMS Conference on
Dynamical Systems, Differential Equations and Applications in Madrid,
Spain, July 7-11, 2014
3. Optimal
Control Problems Arising in Cancer Therapies: Results, Challenges and Open
Problems, the University of Aveiro, Portugal, July 3, 2014.
4. Sufficient Conditions for Strong Local Optimality with
Applications to Biomedical Problems, at the conference Net CO 2014: Conference on New Trends in Optimal Control, Tours,
France June 23-27, 2014,
5. Mathematical Models for Chemotherapy,
the Milan Metronomic and Anti-angiogenic Therapy Meeting 2014, the European Institute
of Oncology in Milan, Italy, June 24-25, 2014.
6. Optimal Control of the Tumor Microenvironment at the Technical University of Lodz in Poland,
June 17, 2014
7. The Method of Characteristics Applied to Models for
Cancer Chemotherapy, at the Second
Conference on Dynamical Systems and Applications" the Technical
University of Lodz on June 12, 2014.
8. Control of the Tumor Microenvironment: Geometric Insights at the INdAM Workshop
on Analysis and Geometry in Control Theory and its Applications in Rome,
Italy, June 9-13, 2014.
9. `Geometric Optimal Control Applied to Combination
Therapies for Cancer: Results and Open Problems at Yonsei University, Seoul, South Korea, May 15,
2014.
10.
'Towards Metronomic Chemotherapy: The Role of
the Tumor Microenvironment in Optimal Drug Administration' at the International Workshop on "Applications
of Ecological and Mathematical Theory to Cancer: New Challenges in
NIMS Daejeon, South Korea, May 12-14, 2014.
11.
Heterogeneous
Tumors and Their Microenvironment: An optimal control approach to Anticancer
Therapies, Arizona State University,
March 6, 2014.
12.
On the control of
cell migration and proliferation in glioblastoma, 52nd IEEE Conference on Decision and Control,
Florence, Italy, December 7-10, 2013.
13.
Combination therapies
for cancer as multi-input optimal control problems: Challenges and Open
Questions, Dept. of Mathematics, University
of Kansas, Lawrence, Kansas, October 21, 2013.
14.
Dynamics of tumor
microenvironment and metronomic chemotherapy, International Symposium on Biomathematics and Ecology, Education and
Research, BEER, Washington, DC, October 11-13, 2013.
15.
On the structure
of optimal protocols for anti-cancer therapies: an optimal control approach, part
I, Workshop on Control and Observation of
Nonlinear Control Systems with Application to Medicine, University of
Hawai'i at Mānoa, September 5-7, 2013.
16.
Optimal control
of cell migration in glioblastoma, 2013 AARMS Mathematical Biology Workshop,
Memorial University, St. John’s, Newfoundland, Canada, July 27-29, 2013.
17.
Geometric methods in optimal
control theory applied to problems in biomedicine, Between Theory and Applications - Mathematics in Action, Będlewo, Poland, June 16-22, 2013.
18.
Controlling
miR-451 in glioblastoma through optimizing glucose intake,
Annual Meeting of the Society for
Mathematical Biology, Tempe, AZ, June 10-13, 2013.
19.
Optimal tumor responses
to antiangiogenic therapies, Annual Meeting of the Society for Mathematical Biology, Tempe, AZ,
June 10-13, 2013.
20.
Cell migration
and proliferation in glioblastoma as an optimal control
problem with state space constraints, Conference
on Dynamical Systems and Applications in honor of Avner Friedman, Łódź University of Technology, Łódź, Poland, May 7, 2013.
21.
Timing and dosage
of anti-cancer drug therapies: an optimal control approach, School of Pharmacy,
Southern Illinois University,
Edwardsville, March 22, 2013.
22.
Challenges in Synthesis of Optimal Controls
For Problems Arising in Biomedicine, ITN SADCO meeting, January 24-25,
2013, Madeira, Portugal
23.
Tumor-Immune Interactions And The
Microenvironment: An Optimal Control Approach, International Workshop on
Mathematical Models of Tumor-Immune System Dynamics, January 7-10, 2013,
Sydney, Australia,
24.
Controlling Tumor Growth through its
Microenvironment, International Symposium on Biomathematics and Ecology,
November 10-11, 2012, St. Louis, Mo, USA
25.
On optimal
protocols for combinations of chemo- and immunotherapy, 51st IEEE Conference on Decision and Control, December 11-14, Maui,
Hi, USA
26.
The role of vasculature
and the immune system in optimal protocols for cancer therapies, UT Austin-Portugal Workshop on Modeling and
Simulation of Physiological Systems, December 6-8, 2012, Lisbon, Portugal
27.
Optimal Control Applied to Mathematical Models of Cancer Combination
Therapies at the International Workshop of Mathematical Modelling of Biological
Processes, Harbin, China, September 3-7,
2012.
28.
Timing and
Dosages of Cancer Treatments-An Optimal Control Approach, 2nd Annual Workshop on Cancer Systems Biology, Tumor Metronomics: Timing and Dose Level Dynamics, Boston,
July 17-20, 2012
29.
Robustness and Sensitivity of Optimal
Protocols for Mathematical Models for Multi-drug Cancer Treatments, 9th International Conference on
Dynamical Systems, Differential Equations and Applications, Orlando,
Florida, July 1-5, 2012
30.
Optimal Control
of Multi-Input Systems in Cancer Chemotherapy, the
11th WSEAS International Conference on System Science and Simulation
in Engineering, Singapore, May 11-13, 2012
31.
Analysis and Numerical Simulations of
Optimal Controls in Mathematical Models
for Cancer Treatments, 5th
International Conference on High Order
Scientific Computing Modeling,
Simulation and Optimization of Complex Processes, Hanoi, Vietnam, March 5-9, 2012
32.
Combination Therapies for Cancer as Multi-input Optimal Control Problems, Stellenbosch
University, South Africa, February 2012.
33.
The Role of Pharmacokinetics of Drugs in Optimizing Protocols for
Combination Treatments of Cancer, US-SA Workshop “Mathematical Methods
in Systems Biology and Population Dynamics”, AIMS, Cape Town, January
4-7, 2012
34.
Synthesis of
Optimal Controlled Trajectories in Biomedical Applications, INRIA Saclay, Ecole Polytechnique, Paris,
December 15, 2011
35.
Optimal control
of cancer: challenges, limitations, open questions, Mathematical Oncology, New Challenges for Systems Biomedicine, Erice, September 26-30, 2011
36.
Optimization of Multi-Input Control Systems Arising in Combination
Therapies for Cancer, AFG Conference on Optimization, Toulouse, September 19-23, 2011
37.
Multi-Input
Optimal Control Problems Arising in Mathematical Models for Combination
Therapies of Cancer, SIAM Conference on
Control and Applications, Baltimore, July 25-27, 2011
38.
Optimal protocols
for chemo- and immunotherapy in a mathematical model of tumor-immune
interactions, European Conference of
Mathematical and Theoretical Biology, Krakow, June 29-July 3, 2011.
39.
Analysis of
Multi-input Optimal Control Problems for Combination Therapies of Cancer, Casablanca International Workshop on
Mathematical Biology, June 20-24, 2011.
40.
Challenges in
Mathematical Modeling of Novel Cancer Treatments: An Optimal Control Approach, International Conference of Mathematics of
Date, Allahabad, India, December 31- January 4, 2011
41.
An Optimal Control Approach to Cancer Treatment under Immunological
Activity, 49th IEEE Conference on Decision and Control, December
14-18, 2010
42.
Optimizing Cancer
Treatments under Tumor-Immune System Interaction, Midwest Optimization Conference, October 8-9, 2010
43.
On a mathematical model of combined anti-angiogenic
and radiotherapy treatment, 16th
Conference on Applications of Mathematics to Biology and Medicine, Krynica, Poland, September 14-18, 2010
44.
Optimal and Realizable Suboptimal Protocols for Anti-Angiogenic
and Combination Therapies, Workshop on Mathematical Modelling of Cancer Growth
and Treatment, University of Dundee,
United Kingdom, August 27-29, 2010
45.
Optimal and
Suboptimal Protocols for Anti-Angiogenic and
Combination Therapies Institute of
Medical Biomathematics, Bene Ataroth, Israel,
June 13, 2010
46.
Minimizing Tumor
Volume for Mathematical Models of Combined Chemotherapy and Anti-Angiogenic Treatment with Pharmacokinetics: Optimal and
Realizable Suboptimal Protocols, 8th
AIMS Conference on Dynamical Systems, Differential Equations and Applications,
Dresden, Germany, May 25-18, 2010
47.
Optimal Control of Cancer Immune System Interactions under Treatment, 8th
AIMS Conference on Dynamical Systems, Differential Equations and Applications, Dresden, Germany, May 25-28, 2010.
48.
Analysis of
mathematical models for cancer treatments: search for optimal protocols, University of Lodz, Poland, May 2010.
49.
Can Mathematics Cure Cancer? Challenges in Mathematical Models for Cancer Treatments, William and Margaret Going Professorship Lecture, Southern Illinois University, Edwardsville,
April 2010.
50.
Mathematical Models for Tumor Anti-Angiogenesis: Optimal and Suboptimal
Protocols and the Role of Pharmacokinetics, Workshop
on Mathematical Methods in Systems Biology, Tel Aviv, Israel, January 4-7, 2010
51.
Bang-bang and
singular controls in mathematical model for combined anti-angiogenic
and chemotherapy treatment, 48th IEEE
Conference on Decision and Control, CDC 2009, Shanghai, China, December
16-18, 2009
52.
Optimizing Treatment
Protocols in Mathematical Models for Combination Therapies in Cancer, Midwest Optimization Conference, Western
Michigan State University, Kalamazoo, Michigan, October 17, 2009
53.
On optimal
control for a model of cancer treatment with immunological activity, Conference
on Applications of Mathematics in Biology and Medicine, Szczyrk,
Poland, September 15-19, 2009.
54.
Optimal controls
minimizing tumor volume for a mathematical model of combination therapy, 14th Belgium-French-German
Conference on Optimization, Leuven, Belgium, September
14-18, 2009.
55.
On the structure
of optimal protocols for a mathematical model of tumor anti-angiogenic
therapy with linear pharmacokinetics, at
the 3rd IEEE Multi Conference
on Systems and Control, Saint Petersburg, Russia, July 8-10, 2009.
56.
Analysis of Mathematical Models for Tumor Anti-Angiogenesis and
Combination Therapy, at the Westfälische Wilhelms Universität, Muenster,
Germany, July 15, 2009.
57.
What can optimal
control tell us about cancer treatments? At the Workshop “The Power, Beauty and Excitement of a Field
that Spans Science, Technology, Engineering and Mathematics” held in
connection with June 9, 2009. 2009
American Control Conference, St. Louis, MO, June 10-12, 2009.
58.
The effect of
pharmacokinetics on optimal protocols for a mathematical model of tumor anti-angiogenic therapy,
2009 American Control Conference, St. Louis, June 10-12, 2009
59.
Optimal Control
of Mathematical Models for Cancer Treatments, A series of three lectures given
at the Silesian Technical University,
Poland May 11, 13, 14, 2009
60.
Optimal and suboptimal realizable protocols for a mathematical model of
administration of anti-angiogenic agents, School of Pharmacy, SIUE, March 2009
61.
Optimal and
realizable protocols for tumor antiangiogenesis and
combination therapy, Lectures on Modeling
of Cancer Growth and Treatments, Estoril,
Portugal, December 8-9, 2008.
62.
The scheduling of
angiogenic inhibitors minimizing tumor volume, XIII International Conference on
Medical Informatics and Technologies, Szczawnica,
Poland, October 16-18, 2008.
63.
Optimal protocols
for cancer: anti-angiogenesis, Part I and II, at the University of Lodz,
October 7 and 15, 2008.
64.
Singular controls
and chattering arcs in synthesis of optimal solutions for mathematical models
in biomedicine, International Conference
“50 years of Optimal Control Theory” Bedlewo,
Poland, September 15-20, 2008.
65.
Application of
optimal control to mathematical models of cancer growth and treatment,
Conference on Application of Mathematics to Biology and Medicine, Leszno, Poland, September 17-20, 2008.
66.
Application of
optimal control to mathematical models for cancer, the Fifth International Conference on Applied Mathematics and Computing,
Plovdiv, Bulgaria, August 12-18, 2008.
67.
On dynamical
systems describing tumor growth under novel treatments, 12th WSEAS International Conference on Systems, Crete,
Greece, July 22-24, 2008.
68.
Analysis of
Mathematical Models for Novel Cancer Treatments, World Congress of Nonlinear Analysts, July 2008.
69.
Multi-control
problems arising in cancer treatments combining angiogenic
inhibitors with chemotherapy, the 7th International Conference on
Dynamical Systems, Differential Equations and Applications, Arlington,
Texas, May 2008
70.
Mathematical
models of novel cancer therapies as optimal control problems, at the Department
of Mathematics, University of Hawaii,
March 2008
71.
Optimal
and suboptimal protocols for a class of mathematical models of tumor growth
under angiogenic inhibitors, First Joint AMS-NZMS International Meeting, Victoria University of
Wellington, New Zealand, December 2007
72.
Synthesis
of optimal controls for mathematical models of tumor anti-angiogenesis, First Joint AMS-PTM International Meeting,
Warsaw University, Warsaw, Poland, August 2007
73.
A
comparison of optimal and sub-optimal strategies for models of tumor
anti-angiogenesis, Part I, 23rd IFIP TC7 Conference on Modeling and
Optimization, AGH University of Science and Technology, Cracow, Poland, July
2007
74.
Dynamics
and control of cancer growth under anti-angiogenic
treatment, Fifth International Conference
on Dynamical Systems and Applications, Morehouse College, Atlanta, June
2007
75.
Optimal
protocols for mathematical models of tumor anti-angiogenesis, Universidad Mayor de San Marcos, Lima,
Peru, Colloquium’s talk, March 2007
76.
Application
of optimal control to mathematical models of tumor anti-angiogenesis, Arizona State University, Dept. of
Mathematics, Colloquium’s talk, February 2007
77.
Control
of dynamical systems in models for cancer treatments, (plenary talk) Fifth
WSEAS Conference on Systems Science and Simulation in Engineering,
Tenerife, Spain, December 2006
78.
Singular
controls in systems describing tumor anti-angiogenesis, Fifth WSEAS
Conference on Systems Science and Simulation in Engineering, Tenerife,
Spain, December 2006
79.
Minimizing
the tumor size in mathematical models for novel cancer treatment:
anti-angiogenesis, Eighth Midwest Optimization Conference, Miami
University, Oxford, OH, October 2006
80.
Application
of optimal control to a system describing tumor anti-angiogenesis, 17th
International Symposium on Mathematical Theory of Networks and Systems
(MTNS), Kyoto, Japan, July 2006,
81.
A
comparison of optimal controls for mathematical models of tumor
anti-angiogenesis, World Conference on Differential Equations and
Applications (EQUA-DIFF 06), Marrakech, Morocco, June 2006
82.
An
Optimal Control Approach to Mathematical Models of Tumor Anti-Angiogenesis Dept.
of Mathematics and Applied Mechanics, Warsaw University, Warsaw, Poland,
June 2006
83.
New
perspectives in control of biomedical systems, (plenary talk) ICGST International Conference on Automatic
Control and System Engineering ACSE-05, Cairo, Egypt, December 19-21, 2005.
84.
Optimal
Control for a System Modelling Tumor Anti-Angiogenesis, ICGST
International Conference on Automatic Control and System Engineering ACSE-05,
Cairo, Egypt, December 19-21, 2005.
85.
A
synthesis of optimal controls for a model of tumor growth under angiogenic inhibitors, the 44rd IEEE Conference on
Decision and Control, Seville, Spain, December 12-15, 2005.
86.
Analysis
of new mathematical models in biomedicine, Lodz University, Poland,
December 6, 2005.
87.
New
directions in analysis and optimal control of biomedical systems, The Stefan
Banach International Mathematical Center, Polish
Academy of Sciences, Warsaw, Poland, December 8, 2005
88.
Optimal
control for mathematical models of cancer treatments under evolving drug
resistance, Imperial College, London, England, June 9, 2005.
89.
Analysis
of optimal controls for a mathematical model of tumor anti-angiogenesis,
Workshop on Angiogenesis and Other Aspects of Tumor Growth, Warsaw
University, Poland, June 15, 2005.
90.
Application
of optimal control to modeling of a new method of cancer treatment:
anti-angiogenesis, Lodz University, Poland, June 19, 2005.
91.
Modeling
and dynamics for the optimal control of tumor anti-angiogenesis, International Workshop
on Differential Equations and Dynamic Systems, Guelph, Canada, July 29 --
July 31, 2005.
92.
Challenges
in mathematical modeling of cancer treatments, Biotechnology and Bioengineering
Symposium, SIUE, April 15, 2005.
93.
Dynamics
of HIV infection: Complexity of models, treatments, Biotechnology and
Bioengineering Symposium, SIUE, April 15, 2005.
94.
New
hope for cancer treatments: Anti-tumor angiogenesis, analysis of a mathematical
model, Biotechnology and Bioengineering Symposium, SIUE, April 15, 2005.
95.
Application
of optimal control to models for treatment of cancer and HIV, Department of
Mathematics and Statistics, SIUE, May 2005.
96.
The
role of PK/PD and drug resistance in models for cancer chemotherapy, International
Conference on Medical Information and Technologies, Miedzybrodzie
Zywieckie, Poland, October 2004
97.
The
role of pharmacokinetics (PK) and pharmacodynamics (PD) in models for cancer
chemotherapy, Fourth World Congress of Nonlinear Analysis, Orlando,
Florida, July 2004.
98.
International
Collaboration Research Grants Opportunities in Science and Engineering,
Luncheon “Women in Analysis” at Fourth World Congress of
Nonlinear Analysis, Orlando, Florida, July 2004.
99.
Application
of control theory in modeling of cancer chemotherapy, International
Conference on Control, Automation and Systems, Bangkok, Thailand, August
2004
100.
Analysis
of the bone marrow model with pharmacokinetics (PK), Symposium on Nonlinear
Analysis, Lodz, Poland, January 2004
101.
Optimal
control for a bilinear model with recruiting agent in cancer chemotherapy, IEEE
Conference on Decision and Control, Maui, December 2003.
102.
Mathematical
Methods for the Analysis of Optimal Controls in Compartmental Models for Cancer
Chemotherapy, Workshop on Mathematical Modeling of Cell Proliferation and
Cancer Chemotherapy, Mathematical Biosciences Institute, Columbus, Ohio,
November 2003
103.
Analysis
of optimal controls for a class of biomedical systems, 24th Colóquio Brasileiro de Matemática, Rio de Janeiro, Brazil, July 2003.
104.
The
role of the objective in the control of biomedical models, Silesian
Technical University, Gliwice, Poland, June 2003
105.
Control
of diseases with strong cell proliferation rates: cancer and HIV, University
of Lodz, Poland, June 2003
106.
Local
optimality of extremals in mathematical models for
chemotherapy, CIMPA School and Workshop on Geometric Non-linear Control,
Campinas, Brazil, July 2003
107.
The
Role of Dynamics and Objective in Modeling Cancer Chemotherapy, Fourth
International Conference on Dynamic Systems and Application,Atlanta, Georgia, May 21-24, 2003
108.
Compartmental
models for cancer chemotherapy, Department of Math. and
Stat., SIUE, May 2003.
109.
Sufficient
conditions for optimality of controls in biomedical systems, 41st
IEEE Conference on Decision and Control (CDC), L
110.
A
comparison of optimal controls for a model in cancer chemotherapy with L1-
and L2-type objectives, International Conference on
Optimization Methods and Software, Hangzhou, China, December 2002
111.
Sufficient
conditions for optimal controls in biomedical systems, 1st Junior
European Meeting on Control Theory and Stability, University of Bourgogne,
Dijon, France, October 2002
112.
Optimality
conditions for a cl
113.
Optimal
controls for a two-compartment model for cancer chemotherapy with quadratic
objective”, 5th Portuguese Conference on Automatic Control
(Controlo 2002), Aveiro,
Portugal, September 2002
114.
Analysis
of optimal controls for mathematical models of chemotherapy for cancer and HIV,
University of Porto, Porto, Portugal, September 2002
115.
Analysis
of optimal controls for mathematical models of chemotherapy for cancer and HIV,
University of Minho, Guimaraes, Portugal,
September 2002,
116.
“On
optimal controls for a general mathematical model for chemotherapy of
HIV”, at the 2002 American Control Conference, Anchorage, Alaska,
May 2002.
117.
“Optimal
control for a general cl
118.
“On
a synthesis of optimal controls for a mathematical model of cancer
chemotherapy”, at the SIAM Conference on Control, San Diego, CA,
July 11-14, 2001.
119.
“On
optimal controls for a 3-compartment model of cancer chemotherapy,” at IASTED
International Conference on Control and Applications, Banff, Canada, June
27-29, 2001.
120.
“On
generalizations of the Euler-Lagrange equation”, at the Third World
Congress of Nonlinear Analysts, Catania, Italy, July 2000.
121.
“Optimal
control of mathematical models in cancer chemotherapy”, Colloquium talk at the University of Lodz, Lodz, Poland, June
2000.
122.
“On
the synthesis of controls for a mathematical model of cancer
chemotherapy,” 39th IEEE Conference on Decision and Control,
Sydney, Australia, December 2000.
123.
“Optimal
control for a mathematical model of cancer chemotherapy”, at IASTED
International Conference on Control and Applications, Cancun, Mexico, May
2000.
124.
“Perturbation
feedback control law and its generalizations”, Colloquium talk at the University of Lodz, Lodz, Poland, June
1999.
125.
“High-order
local Maximum Principle: theory, comparisons, examples”, Colloquium talk
at Center for Viability and Control, Dauphine University, Paris, France,
May 1999.
126.
“Perturbation
feedback control and neighboring extremals in
abnormal cases”, at IASTED International Conference on Control and
Applications, Honolulu, Hawaii, August 1998.
127.
“High-order
approximations in optimal control theory: A comparison of normal, abnormal and
singular cases”, at the 13-th International Symposium on Mathematical
Theory of Networks and Systems, Padova, Italy,
July 1998.
128.
“High-order
approximations in optimization and optimal control,” Colloquium talk at University of Florence, Florence, Italy, June
1998.
129.
“High-order
approximations for abnormal bang-bang extremals”,
at the 18th IFIP Conference on Optimization and Mathematical
Modeling, Detroit, MI, July 21-25, 1997.
130.
“Comparison
of first, second and third order approximations in optimal control: conditions
for accessory problem”, Colloquium talk at the University of Lodz,
Lodz, Poland, June 1997.
131.
“High-order
Maximum Principle”, at the Conference on Optimal Control: Theory,
Methods and Applications, at the University of Florida, Gainesville,
February 27-March 1, 1997.
132.
“High-order
approximations with applications to abnormal problems in optimization and
optimal control”, Colloquium talk at the Florida
Institute of Technology, February 24, 1997.
133.
"A
high-order generalization of the Lyusternik theorem
without surjectivity condition and its application to
optimization", Second World Congress of Nonlinear Analysts, Athens,
July 1996.
134.
"Optimality
Conditions for Control Problems Governed by Abstract Semilinear
Differential Equations in Complex Banach Space",
at the International Conference on Dynamical Systems and Differential
Equations, Springfield, Missouri, June 1996.
135.
"On
high-order tangent cones and their applications in optimal control", 12-th
International Symposium on the Mathematical Theory of Networks and Systems
(MTNS-96), St. Louis (Missouri), June 24-28, 1996.
136.
"Extended
Maximum principle and second-order condition for abnormal problems in optimal
control", Colloquium Talk at the Institute of Mathematics, Lodz
University, Lodz (Poland), January 1996
137.
"On
a new type of approximating cones in optimization and extended Maximum
Principle", at the University of Rhode Island, Kingston, August 16,
1995
138.
"Second
order Dubovitskii-Milyutin theory and second order
optimality conditions to abnormal optimal control problems", at a Special
Session on Nonlinear Dynamics, Annual Meeting of AMS, San Francisco,
January 1995.
139.
"Nontrivial
optimality conditions in abnormal optimal control problems”, at the Third
SIAM Conference on Control and Applications,
140.
"Second
order approximating cones for abnormal problems in optimization and optimal
control", International Congress of Mathematicians, ICM94,
141.
"Extension
of the Dubovitskii-Milyutin method to second order
approximating cones and its applications", at the Session of Polish
Mathematical Society,
142.
"First
and second order conditions for optimality II. abnormal
optimal control problems", at the Conference on Optimization,
143.
"On
abnormal problems in optimization and optimal control", at the Department
of Applied Mathematics,
144.
"Pareto
optimality conditions for abnormal optimization and optimal control
problems", at the Conference on Optimal Control,
145.
"Generalizations
of the Lusternik theorem and their applications to nonsmooth and abnormal problems in optimization and optimal
control", at the First World Congress of Nonlinear Analysts,
146.
"On
some type of higher order conditions for optimality and their applications to
abnormal problems in control theory", at the Session of Polish
Mathematical Society,
147.
"An
extension of Maximum Principle for abnormal problems", at the Summer
School on Control Theory, University of Montreal, Montreal, Canada, July
26-August 7, 1992.
148.
"On
a certain type of Higher Order Maximum Principle (HMP)", at the AMS
Annual Meeting in Baltimore, January 1992.
149.
"Abnormalities
in optimal control problems of distributed parameter systems in Banach spaces", at the 20-th Midwest Conference of
Differential Equations in
150.
"On
nonregular optimization and abnormal optimal control
problems", at Second International Conference of Industrial and Applied
Mathematics, ICIAM 91,
151.
"Optimality
conditions for abnormal optimal control problems of with additional equality
constraints", at International Conference on the Theory and
Applications of Differential Equations in
152.
"Necessary
conditions of optimality and Pareto optimality for abnormal optimization and
optimal control problems", at Optimization Days,
153.
"On
the Dubovitskii-Milyutin method and abnormal optimal
control problems", at the Department of Systems Science and Mathematics, Washington
University, April 1991
154.
"On
some extension of the Pontryagin type maximum
principle to the abnormal optimal control problems", at the AMS Annual
Meeting in
155.
"Optimality
conditions for abnormal optimal control problems of systems with terminal
data", at the International Conference on the Theory of Differential
Equations and Applications to Oceanography, Goa University (India),
December 17-21, 1990.
156.
"On
an abnormal optimal control problem", at the International Conference
on Mathematical Theory of Control, IIT Bombay (
157.
"On
optimal control of distributed parameter systems with terminal data", at the
Nineteenth Annual Midwest Differential and Integral Equations Conference,
Rolla (
158.
"On
optimization problems in the nonregular cases and
abnormal optimal controls", at Florida
Institute of Technology,
159.
"Conditions
of optimality and Pareto optimality in nonregular extremum problems in Banach
spaces and their applications to abnormal optimal control problems", at
the XIX Conference of Applied Mathematics, Pradocin
(
160.
"The
Euler - Lagrange equations for nonregular extremum problems in Banach
spaces", at the AMS Annual Meeting,
161.
"On
some optimal control problems of parabolic and hyperbolic equations", at
the Midwest Conference on Differential Equations,
162.
"Application
of the Moser's technique to the tangent direction problem for nonlinear
evolution equations", at the International Conference on Differential
Equations, Theory and Applications to Stability and Control, Colorado
Springs, (Colorado), June 7-10, 1989.
163.
"On further extensions of the Dubovitskii-Milyutin
formalism", at the AMS Annual Meeting,
164.
"On
extensions of the Dubovitskii-Milyutin method and
their applications to optimal control of ordinary and partial differential
equations", at Southern Illinois University at Carbondale, January
1989
165.
"Application
of some specifications of the Dubovitskii-Milyutin
theorem to optimal control problems with additional equality constraints",
at the
166.
"On
some optimal control problems of differential equations with additional
equality contraints", at the International
Conference in Honor of Solomon Lefschetz and
Joseph P.LaSalle ``30 Years of Modern Optimal Control
Theory,"
167.
"Application
of Global Linearization Iterative Methods to general optimal control problems
in Banach spaces", at the International
Conference on Theory and Applications of Differential Equations,
168.
"The
Euler-Lagrange equation in the presence of unbounded operator constraints"
at the AMS Annual Meeting ,
169.
"On
generalizations of the Duboviskii-Milyutin theorem in
optimization and their applications", at Southwest Texas State
University,
170.
"Application
of optimization methods under Frechet and Gateaux
differentiability in Banach spaces to optimal control
problems", at the
171.
"Some
extensions of the Dubovitskii-Milyutin formalism and
their applications to optimal control problems", at Southern Illinois
University, Edwardsville, March 1987
172.
"On
the Dubovitskii-Milyutin formalism in the case of many
equlity constraint and its applications to optimal
control of systems governed by ordinary and partial differential
equations" at the University of California, Irvine, February 1987
173.
"On
the optimization and optimal control problems with many equality constraints"
at the
174.
“Application
of the method of contractor directions to optimization and optimal
control” at the AMS Annual Meeting,
175.
“Applications
of the method of contractor directions to optimization theory” at the Conference
of Applied Mathematics, Sielpia, 1986
176.
"Optimal
control problems of ordinary and differential equations with equality contraints" at the International Conference on the
Theory Applications of Differential Equations,
177.
"Extremum principle for optimal control problems with mixed
equality constraints" at the
178.
"On
the optimal control problems of ordinary differential equations with equality
constraints" at the Session of the Polish Mathematical Society,
March, 1984
179.
"On
some methods in discrete optimization", at the Conference of Applied
Mathematics, Burzenin, 1981
Urszula Ledzewicz / uledzew@siue.edu / Updated: February 20, 2013